Company Profile

Fulgent Genetics, Inc. Stock Price, News & Catalysts

Ticker:
FLGT
Exchange:
NASDAQ
Sector:
MedTech
Location:
United States

Stock performance

24.78 USD (-1.39%)

Close

Last updated: November 19, 2026

531M USD

Market cap

Why the stock is moving

As of Nov 19, 2026, FLGT closed down 1.39% at $24.78. No new same-company headline was identified in the current news window.

Company overview

Precision Medicine Business

Fulgent Genetics operates a laboratory-services business alongside a therapeutic-development portfolio. The company aims to combine diagnostic capabilities with drug development to become an integrated precision-medicine organization.

Laboratory Services

Fulgent provides technical laboratory testing and physician interpretation services. Its operations include genetic and specialty diagnostic capabilities serving healthcare providers, institutions and other customers.

Oncology Therapeutics

The therapeutic business uses nanoencapsulation and targeted-delivery technology to improve the pharmacokinetics and therapeutic window of cancer drugs. Clinical candidates FID-007 and FID-022 represent the lead applications of this platform.

Integrated Diagnostics and Drug Development

The combination of laboratory testing, genomic interpretation and therapeutic research gives Fulgent access to clinical data and operational capabilities across the precision-medicine value chain.

Future catalysts

    Recent news

    1. 01
    2. 02
    3. 03
    4. 04
    5. 05

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Fulgent Genetics, Inc. (FLGT)?

    Fulgent Genetics, Inc. (FLGT) most recently closed at 24.78 USD, a -1.39% move versus the previous session.

    What is the market cap of Fulgent Genetics, Inc. (FLGT)?

    Fulgent Genetics, Inc. currently has a market capitalization of 531M USD on BioPharmSignal.

    What does Fulgent Genetics, Inc. do?

    Precision Medicine Business Fulgent Genetics operates a laboratory-services business alongside a therapeutic-development portfolio. The company aims to combine diagnostic capabilities with drug development to become an integrated precision-medicine organization. Laboratory Services Fulgent provides technical laboratory testing and physician interpretation...

    On which exchange is FLGT stock listed?

    Fulgent Genetics, Inc. (FLGT) is associated with NASDAQ, United States, MedTech.

    What is FID-007?

    Clinical candidates FID-007 and FID-022 represent the lead applications of this platform.

    Which conditions is Fulgent Genetics, Inc. targeting with FID-007?

    Fulgent Genetics, Inc. is associated with oncology, cancer therapeutics, genetic disease based on its company overview and current catalyst commentary.

    What is FID-022?

    Clinical candidates FID-007 and FID-022 represent the lead applications of this platform.

    What is Precision?

    Precision Medicine Business Fulgent Genetics operates a laboratory-services business alongside a therapeutic-development portfolio.